Parkinson's Disease and Post-COVID-19 Syndrome: The Parkinson's Long-COVID Spectrum

Valentina Leta, Mayela Rodríguez-Violante, Arturo Abundes, Katarina Rukavina, James T Teo, Cristian Falup-Pecurariu, Laura Irincu, Silvia Rota, Roongroj Bhidayasiri, Alexander Storch, Per Odin, Angelo Antonini, Kallol Ray Chaudhuri, Valentina Leta, Mayela Rodríguez-Violante, Arturo Abundes, Katarina Rukavina, James T Teo, Cristian Falup-Pecurariu, Laura Irincu, Silvia Rota, Roongroj Bhidayasiri, Alexander Storch, Per Odin, Angelo Antonini, Kallol Ray Chaudhuri

No abstract available

Keywords: COVID-19; Long COVID; Parkinson's disease; Post-COVID-19 syndrome; SARS-CoV-2.

References

    1. Antonini A, Leta V, Teo J, Chaudhuri KR. Outcome of Parkinson's disease patients affected by COVID‐19. Mov Disord 2020;35(6):905–908.
    1. Zhang Q, Schultz JL, Aldridge GM, Simmering JE, Narayanan NS. Coronavirus disease 2019 case fatality and Parkinson's disease. Mov Disord 2020;35(11):1914–1915.
    1. Sulzer D, Antonini A, Leta V, et al. COVID‐19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside. NPJ Parkinsons Dis 2020;6:18. 10.1038/s41531-020-00123-0
    1. Artusi CA, Romagnolo A, Imbalzano G, et al. COVID‐19 in Parkinson's disease: Report on prevalence and outcome. Parkinsonism Relat Disord 2020;80:7–9. 10.1016/j.parkreldis.2020.09.008
    1. Cilia R, Bonvegna S, Straccia G, et al. Effects of COVID‐19 on Parkinson's disease clinical features: a community‐based case‐control study. Mov Disord 2020;35(8):1287–1292.
    1. National Institute for Health and Care Excellence (NICE) . COVID‐19 rapid guideline: managing the long‐term effects of COVID‐19. . Accessed February 1, 2021.
    1. Davis HE, Assaf GA, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. medRxiv 2020. 10.1101/2020.12.24.20248802

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner